Gordon Asset Management

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 1, 2021	C2i Genomics	$100.0M Series B	Casdin Capital	Album VC, NFX, Alexandria Venture Investments, Driehaus Capital Management, Duquesne Family Office, iGlobe Partners, LionBird, NFX, Section 32, Silver Lake, The Mark Foundation for Cancer Research

Total Raised

N/A

Valuation

N/A